FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:HIVEP3-PRRG1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: HIVEP3-PRRG1
FusionPDB ID: 36563
FusionGDB2.0 ID: 36563
HgeneTgene
Gene symbol

HIVEP3

PRRG1

Gene ID

59269

5638

Gene nameHIVEP zinc finger 3proline rich and Gla domain 1
SynonymsKBP-1|KBP1|KRC|SHN3|Schnurri-3|ZAS3|ZNF40CPRGP1
Cytomap

1p34.2

Xp21.1

Type of geneprotein-codingprotein-coding
Descriptiontranscription factor HIVEP3ZAS family, member 3human immunodeficiency virus type I enhancer binding protein 3kappa-B and V(D)J recombination signal sequences-binding proteinkappa-binding protein 1zinc finger protein ZAS3transmembrane gamma-carboxyglutamic acid protein 1proline rich Gla (G-carboxyglutamic acid) 1proline-rich Gla (G-carboxyglutamic acid) polypeptide 1
Modification date2020031320200313
UniProtAcc

Q5T1R4

Main function of 5'-partner protein: FUNCTION: Plays a role of transcription factor; binds to recognition signal sequences (Rss heptamer) for somatic recombination of immunoglobulin and T-cell receptor gene segments; Binds also to the kappa-B motif of gene such as S100A4, involved in cell progression and differentiation. Kappa-B motif is a gene regulatory element found in promoters and enhancers of genes involved in immunity, inflammation, and growth and that responds to viral antigens, mitogens, and cytokines. Involvement of HIVEP3 in cell growth is strengthened by the fact that its down-regulation promotes cell cycle progression with ultimate formation of multinucleated giant cells. Strongly inhibits TNF-alpha-induced NF-kappa-B activation; Interferes with nuclear factor NF-kappa-B by several mechanisms: as transcription factor, by competing for Kappa-B motif and by repressing transcription in the nucleus; through a non transcriptional process, by inhibiting nuclear translocation of RELA by association with TRAF2, an adapter molecule in the tumor necrosis factor signaling, which blocks the formation of IKK complex. Interaction with TRAF proteins inhibits both NF-Kappa-B-mediated and c-Jun N-terminal kinase/JNK-mediated responses that include apoptosis and proinflammatory cytokine gene expression. Positively regulates the expression of IL2 in T-cell. Essential regulator of adult bone formation. {ECO:0000269|PubMed:11161801}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000247584, ENST00000372583, 
ENST00000372584, ENST00000429157, 
ENST00000460604, 
ENST00000449135, 
ENST00000491253, ENST00000542554, 
ENST00000543642, ENST00000463135, 
ENST00000378628, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score21 X 18 X 10=37803 X 3 X 2=18
# samples 254
** MAII scorelog2(25/3780*10)=-3.91838623444635
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/18*10)=1.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: HIVEP3 [Title/Abstract] AND PRRG1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: HIVEP3 [Title/Abstract] AND PRRG1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)HIVEP3(42041215)-PRRG1(37312389), # samples:1
Anticipated loss of major functional domain due to fusion event.HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
HIVEP3-PRRG1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneHIVEP3

GO:0045893

positive regulation of transcription, DNA-templated

15790681



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:42041215/chrX:37312389)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across HIVEP3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PRRG1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000372583HIVEP3chr142041215-ENST00000378628PRRG1chrX37312389+10253609388661831765

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000372583ENST00000378628HIVEP3chr142041215-PRRG1chrX37312389+0.0013369090.99866307

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for HIVEP3-PRRG1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
HIVEP3chr142041215PRRG1chrX3731238960931736RGEPARIKIFEGGRSFGAPTQKRNKG

Top

Potential FusionNeoAntigen Information of HIVEP3-PRRG1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
HIVEP3-PRRG1_42041215_37312389.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:01KIFEGGRSF0.99940.973716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:25KIFEGGRSF0.99760.9665716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:02KIFEGGRSF0.9970.9667716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:17KIFEGGRSF0.99440.9525716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:16KIFEGGRSF0.99250.757716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B57:01KIFEGGRSF0.98830.9838716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:03KIFEGGRSF0.98660.8728716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B57:03KIFEGGRSF0.98350.9882716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B58:02KIFEGGRSF0.97180.9399716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A32:13KIFEGGRSF0.9690.9765716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B58:01KIFEGGRSF0.95530.9488716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:18KIFEGGRSF0.95250.8536716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B46:01KIFEGGRSF0.85730.5153716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A30:08KIFEGGRSF0.64990.8334716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B41:01FEGGRSFGA0.51150.9536918
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B50:01FEGGRSFGA0.31610.9424918
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B13:01KIFEGGRSF0.05060.965716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B52:01KIFEGGRSF0.0250.967716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:05GRSFGAPTQK0.99970.75571222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:04GRSFGAPTQK0.99810.75481222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:03IKIFEGGRSF0.99450.7944616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:18IKIFEGGRSF0.99230.7639616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:01IKIFEGGRSF0.98560.9636616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:02IKIFEGGRSF0.96540.9523616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:25IKIFEGGRSF0.95990.9505616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A30:08GRSFGAPTQK0.86650.84791222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:01RIKIFEGGRSF0.99990.9656516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:05GRSFGAPTQKR0.99990.54591223
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:25RIKIFEGGRSF0.99860.9578516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B46:01RIKIFEGGRSF0.99810.6204516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A32:13RIKIFEGGRSF0.99270.9821516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C04:10IFEGGRSF0.9980.7029816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C04:07IFEGGRSF0.99790.7293816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C04:14IFEGGRSF0.98640.7431816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:07KIFEGGRSF0.99920.8655716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B40:06FEGGRSFGA0.99760.7458918
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:21KIFEGGRSF0.99650.9563716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:04KIFEGGRSF0.98960.9707716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C15:04KIFEGGRSF0.95360.9475716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:05KIFEGGRSF0.94450.9607716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:31KIFEGGRSF0.94090.964716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:10KIFEGGRSF0.92240.9816716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:19KIFEGGRSF0.91580.8049716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:67KIFEGGRSF0.90670.9761716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:80KIFEGGRSF0.90670.9761716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:07KIFEGGRSF0.90160.991716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:08KIFEGGRSF0.8950.9415716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C12:16KIFEGGRSF0.89240.9884716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:05KIFEGGRSF0.89120.8801716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C12:12KIFEGGRSF0.87610.9754716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C15:06KIFEGGRSF0.86840.9498716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:95KIFEGGRSF0.86120.7953716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:19KIFEGGRSF0.85610.9944716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:46KIFEGGRSF0.84390.9391716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:27KIFEGGRSF0.81840.9732716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C06:03KIFEGGRSF0.76230.9982716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C12:04KIFEGGRSF0.76090.9981716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:14KIFEGGRSF0.68970.99716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C02:06KIFEGGRSF0.45850.9889716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:14GRSFGAPTQK0.99940.75921222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:03GRSFGAPTQK0.99640.77441222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:04IKIFEGGRSF0.98510.9623616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:07IKIFEGGRSF0.98340.8678616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:05IKIFEGGRSF0.90970.9543616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:07RIKIFEGGRSF0.99960.9184516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:04RIKIFEGGRSF0.99940.9766516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:05RIKIFEGGRSF0.9880.9655516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C04:01IFEGGRSF0.99790.7293816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C18:01IFEGGRSF0.99780.733816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C14:02IFEGGRSF0.99390.979816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C14:03IFEGGRSF0.99390.979816
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:33KIFEGGRSF0.99940.973716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:27KIFEGGRSF0.99940.9726716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:135KIFEGGRSF0.99940.9673716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:34KIFEGGRSF0.99940.973716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:125KIFEGGRSF0.99940.973716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:35KIFEGGRSF0.99920.9539716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:11KIFEGGRSF0.99910.96716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:50KIFEGGRSF0.99910.9776716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:08KIFEGGRSF0.9990.9516716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:24KIFEGGRSF0.99880.9713716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B35:43KIFEGGRSF0.99850.9516716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:12KIFEGGRSF0.99820.9564716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:53KIFEGGRSF0.9980.9643716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:39KIFEGGRSF0.99770.9306716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A32:01KIFEGGRSF0.99540.9732716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B35:11KIFEGGRSF0.99510.9454716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B58:06KIFEGGRSF0.9940.833716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:13KIFEGGRSF0.99110.7945716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B57:04KIFEGGRSF0.990.6826716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B57:10KIFEGGRSF0.98830.9838716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:54KIFEGGRSF0.97960.9552716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C15:09KIFEGGRSF0.95360.9475716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:68KIFEGGRSF0.95220.7806716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:20KIFEGGRSF0.94670.9704716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B35:28KIFEGGRSF0.92710.9686716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:73KIFEGGRSF0.91810.7894716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:67KIFEGGRSF0.91630.9869716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B35:20KIFEGGRSF0.91540.9709716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:17KIFEGGRSF0.91080.9864716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:02KIFEGGRSF0.90670.9761716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C16:01KIFEGGRSF0.89840.9861716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:03KIFEGGRSF0.89770.9934716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:04KIFEGGRSF0.89770.9934716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:02KIFEGGRSF0.89650.9862716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B57:02KIFEGGRSF0.8950.8864716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C07:01KIFEGGRSF0.88430.7136716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B07:13KIFEGGRSF0.86760.7779716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C12:03KIFEGGRSF0.84560.9937716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C16:04KIFEGGRSF0.84130.9938716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:17KIFEGGRSF0.82910.9828716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:05KIFEGGRSF0.82470.9616716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:30KIFEGGRSF0.82230.9134716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B48:02KIFEGGRSF0.80370.9686716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C12:02KIFEGGRSF0.80160.9903716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C06:06KIFEGGRSF0.78220.9945716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C16:02KIFEGGRSF0.74610.9941716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A25:01KIFEGGRSF0.6150.9697716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:06KIFEGGRSF0.57140.9939716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C06:08KIFEGGRSF0.55570.9961716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C02:10KIFEGGRSF0.50780.9918716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C02:02KIFEGGRSF0.50780.9918716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C14:03KIFEGGRSF0.39680.9803716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C14:02KIFEGGRSF0.39680.9803716
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B50:04FEGGRSFGA0.31610.9424918
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B50:05FEGGRSFGA0.31610.9424918
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:10GRSFGAPTQK0.99950.84881222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B27:08GRSFGAPTQK0.99930.67481222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:54IKIFEGGRSF0.99370.9414616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-C03:02IKIFEGGRSF0.99190.981616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:68IKIFEGGRSF0.99140.775616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:50IKIFEGGRSF0.98820.9694616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:53IKIFEGGRSF0.98640.9541616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:125IKIFEGGRSF0.98560.9636616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:33IKIFEGGRSF0.98560.9636616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:34IKIFEGGRSF0.98560.9636616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:35IKIFEGGRSF0.98490.9544616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:27IKIFEGGRSF0.98490.9672616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:135IKIFEGGRSF0.98430.9584616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B48:02IKIFEGGRSF0.98250.9626616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:12IKIFEGGRSF0.98140.9367616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:24IKIFEGGRSF0.97840.9515616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:39IKIFEGGRSF0.96720.8823616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:13IKIFEGGRSF0.9330.6486616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:20IKIFEGGRSF0.91240.9629616
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A30:01GRSFGAPTQK0.87860.94071222
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:27RIKIFEGGRSF0.99990.9749516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:33RIKIFEGGRSF0.99990.9656516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:135RIKIFEGGRSF0.99990.9741516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:34RIKIFEGGRSF0.99990.9656516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:125RIKIFEGGRSF0.99990.9656516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:24RIKIFEGGRSF0.99990.9585516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:35RIKIFEGGRSF0.99970.9719516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:50RIKIFEGGRSF0.99960.9857516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:12RIKIFEGGRSF0.99940.9646516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B58:06RIKIFEGGRSF0.99880.782516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:39RIKIFEGGRSF0.99870.9079516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:30RIKIFEGGRSF0.99590.9633516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-A32:01RIKIFEGGRSF0.99430.9758516
HIVEP3-PRRG1chr142041215chrX373123896093HLA-B15:20RIKIFEGGRSF0.98710.9723516

Top

Potential FusionNeoAntigen Information of HIVEP3-PRRG1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
HIVEP3-PRRG1_42041215_37312389.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-0437PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-0442PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-0465PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-0473PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-0473EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1452PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1457PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1501PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1501EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1501GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1502PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1503PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1503EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1504PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1504EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1504GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1504ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1505PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1505EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1505GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1505ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1506PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1506EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1506GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1507PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1507EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1507GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1508PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1509PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1509EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1509GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1510PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1510EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1511PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1512PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1512EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1513PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1513EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1513GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1514PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1515PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1515EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1516PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1516EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1516GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1518PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1518EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1518GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1518ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1519PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1520PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1520EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1520GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1521PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1521EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1521ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1521GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1522PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1522EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1522GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1523PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1523EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1524PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1524EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1524GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1526PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1528PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1528EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1528GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1528ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1530PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1531PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1531EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1532PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1532EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1532GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1533PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1533EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1533GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1535PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1535EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1535GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1535ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1536PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1536EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1536GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1536ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1537PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1537EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1537GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1537ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1538PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1539PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1540PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1540EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1540GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1541PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1541EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1541GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1542PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1542EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1542GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1543PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1543EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1543GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1544PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1545PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1545EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1545GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1546PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1546EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1546GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1547PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1548PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1548EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1548GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1549PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1549EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1549GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1549ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1615PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB1-1615EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0103PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0103EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0106PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0106EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0202PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0202EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0202GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0202ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0203PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0204PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0204EPARIKIFEGGRSFG217
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0204GEPARIKIFEGGRSF116
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0204ARIKIFEGGRSFGAP419
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0205PARIKIFEGGRSFGA318
HIVEP3-PRRG1chr142041215chrX373123896093DRB5-0205EPARIKIFEGGRSFG217

Top

Fusion breakpoint peptide structures of HIVEP3-PRRG1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3762IKIFEGGRSFGAPTHIVEP3PRRG1chr142041215chrX373123896093

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of HIVEP3-PRRG1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3762IKIFEGGRSFGAPT-7.15543-7.26883
HLA-B14:023BVN3762IKIFEGGRSFGAPT-4.77435-5.80965
HLA-B52:013W393762IKIFEGGRSFGAPT-6.80875-6.92215
HLA-B52:013W393762IKIFEGGRSFGAPT-4.20386-5.23916
HLA-A11:014UQ23762IKIFEGGRSFGAPT-7.5194-8.5547
HLA-A11:014UQ23762IKIFEGGRSFGAPT-6.9601-7.0735
HLA-A24:025HGA3762IKIFEGGRSFGAPT-7.52403-7.63743
HLA-A24:025HGA3762IKIFEGGRSFGAPT-5.82433-6.85963
HLA-B27:056PYJ3762IKIFEGGRSFGAPT-3.28285-4.31815
HLA-B44:053DX83762IKIFEGGRSFGAPT-5.91172-6.94702
HLA-B44:053DX83762IKIFEGGRSFGAPT-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of HIVEP3-PRRG1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
HIVEP3-PRRG1chr142041215chrX373123891222GRSFGAPTQKAGGAAGGAGTTTTGGAGCACCTACACAAAA
HIVEP3-PRRG1chr142041215chrX373123891223GRSFGAPTQKRAGGAAGGAGTTTTGGAGCACCTACACAAAAGCG
HIVEP3-PRRG1chr142041215chrX37312389516RIKIFEGGRSFGAGGATCAAAATCTTCGAAGGAGGAAGGAGTTT
HIVEP3-PRRG1chr142041215chrX37312389616IKIFEGGRSFGATCAAAATCTTCGAAGGAGGAAGGAGTTT
HIVEP3-PRRG1chr142041215chrX37312389716KIFEGGRSFCAAAATCTTCGAAGGAGGAAGGAGTTT
HIVEP3-PRRG1chr142041215chrX37312389816IFEGGRSFAATCTTCGAAGGAGGAAGGAGTTT
HIVEP3-PRRG1chr142041215chrX37312389918FEGGRSFGACTTCGAAGGAGGAAGGAGTTTTGGAGC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
HIVEP3-PRRG1chr142041215chrX37312389116GEPARIKIFEGGRSFAGGGGAGCCGGCGAGGATCAAAATCTTCGAAGGAGGAAGGAGTTT
HIVEP3-PRRG1chr142041215chrX37312389217EPARIKIFEGGRSFGGGAGCCGGCGAGGATCAAAATCTTCGAAGGAGGAAGGAGTTTTGG
HIVEP3-PRRG1chr142041215chrX37312389318PARIKIFEGGRSFGAGCCGGCGAGGATCAAAATCTTCGAAGGAGGAAGGAGTTTTGGAGC
HIVEP3-PRRG1chr142041215chrX37312389419ARIKIFEGGRSFGAPGGCGAGGATCAAAATCTTCGAAGGAGGAAGGAGTTTTGGAGCACC

Top

Information of the samples that have these potential fusion neoantigens of HIVEP3-PRRG1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADHIVEP3-PRRG1chr142041215ENST00000372583chrX37312389ENST00000378628TCGA-CG-5724-01A

Top

Potential target of CAR-T therapy development for HIVEP3-PRRG1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgenePRRG1chr1:42041215chrX:37312389ENST000003786282484_1060219.0TransmembraneHelical
TgenePRRG1chr1:42041215chrX:37312389ENST000004491353584_1060219.0TransmembraneHelical
TgenePRRG1chr1:42041215chrX:37312389ENST000004631350484_106083.0TransmembraneHelical
TgenePRRG1chr1:42041215chrX:37312389ENST000005425543584_1060219.0TransmembraneHelical
TgenePRRG1chr1:42041215chrX:37312389ENST000005436422484_1060219.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
HIVEP3chr142041215ENST00000372583PRRG1chrX37312389ENST00000378628

Top

Related Drugs to HIVEP3-PRRG1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to HIVEP3-PRRG1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource